🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical Trial Comparing ERCP vs ERCP and Transmural Gall Bladder Drainage

RecruitingNAAges 75 Years - anyAllHospital del Rio Hortega
NCT03921502 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Cholelithiasis occurs in 10-20% of the general population. Up to 18% of these subjects will present symptoms. In patients with symptomatic choledocholithiasis who are not candidates for surgery with indication for ERCP, transmural drainage of the gallbladder reduces the risk of recurrence. The investigators propose a multicentric double-blind randomized trial. Our primary objective is to assess whether ERCP associated with transmural gallbladder drainage is able to reduce biliary disease income compared with ERCP in patients not candidates for surgery with symptomatic choledocholithiasis and cholelithiasis during one year of follow-up. Also the investigators will analyze the proportion of technical success and complications. The study population includes all patients older than 75 years with symptomatic choledocholithiasis. An estimated 75 subjects per group (ERCP alone and ERCP and tr

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Symptomatic choledocholithiasis (choledocholithiasis demonstrated radiologically or highly suspected by clinical data (acute cholangitis or obstructive jaundice), analytical and imaging according to the criteria of high probability of choledocholithiasis established in the clinical guidelines (ASGE Guide). * Discarded for surgical treatment due to age, comorbidity or refusal of the patient. * Age\>75 years Exclusion Criteria: * Charlson comorbidity scale adjusted to age \<4. * Hepatobiliary surgery or previous superior digestive tract. * Ascitis. * Inability to tolerate sedation of endoscopy, perforation of the digestive tract or other contraindication to endoscopy. * Coagulopathy with INR (international normalized ratio) \> 1.5 not correctable or thrombocytopenia \<50000 / mm3 not correctable. * Other diagnoses at admission (acute cholecystitis, acute pancreatitis, biliopancreatic neoplasia). * Hemodynamic instability. * Urgent procedure performed after hours * No availability of expert material / endoscopist in drainage. * Anatomical impossibility of performing biliary drainage (absence of vesicular distension, contact between gallbladder and stomach or duodenum, contact area \<10 mm). * Baseline ECOG (Easthern Cooperative Oncology Group) \> = 4 * Expectancy of survival \<6 months. * Refusal to participate. * Distance between the gallbladder and upper digestive tract\> 1cm, scleroatrophic vesicle, lack of stable acoustic window for drainage * ERCP failed (inhability to dain common bile duct)
💊

What it tests

  • Gall bladder transmural drainage with LAMS
📍

Where

1 site
Hospital Rio Hortega
Valladolid, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy